Sandbox Myopathy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 6: Line 6:
{| class="wikitable"
{| class="wikitable"
! rowspan="3" |Disease
! rowspan="3" |Disease
! colspan="10" |Symptoms
! colspan="9" |Symptoms
! rowspan="3" |History
! rowspan="3" |History
! rowspan="3" |Physical
! rowspan="3" |Physical
Line 13: Line 13:
|-
|-
! rowspan="2" |Age of onset
! rowspan="2" |Age of onset
! rowspan="2" |Site of muscle weakness
! colspan="2" |Muscle weakness
! colspan="2" |Muscle weakness
! rowspan="2" |Fever
! rowspan="2" |Fever
Line 29: Line 28:
!DIstal
!DIstal
|-
|-
! colspan="18" |Medications
! colspan="17" |Medications
|-
|-
|Corticosteroids
|Corticosteroids
|
|
* Variable
* Variable
|Muscle cell
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 65: Line 63:
|
|
* 60+
* 60+
|Muscle cell
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 93: Line 90:
|
|
* Variable
* Variable
|Muscle cell
|      '''+'''
|      '''+'''
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 120: Line 116:
* Normal
* Normal
|-
|-
! colspan="18" |Endocrine  
! colspan="17" |Endocrine  
|-
|-
|Cushing's disease
|Cushing's disease
|
|
* 25 -45
* 25 -45
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 166: Line 161:
|
|
* 30-50 years
* 30-50 years
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 199: Line 193:
|
|
* 50
* 50
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
Line 228: Line 221:
|
|
* 40
* 40
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 258: Line 250:
|
|
* >55
* >55
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 285: Line 276:
|
|
* 45 
* 45 
|
| +
| +
| -
| -
Line 315: Line 305:
* Normal
* Normal
|-
|-
! colspan="18" |Inflammatory / Rheumatologic  
! colspan="17" |Inflammatory / Rheumatologic  
|-
|-
|Dermatomyositis<ref name="pmid1658649">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649  }}</ref>
|Dermatomyositis<ref name="pmid1658649">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649  }}</ref>
Line 321: Line 311:
* 40s-50s
* 40s-50s
* Can affect childreen  
* Can affect childreen  
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
| -
| -
Line 352: Line 341:
|
|
* > 18 years  
* > 18 years  
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
| -
| -
Line 374: Line 362:
|
|
* 50s  
* 50s  
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
| +
| +
Line 394: Line 381:
|
|
* 40-50s  
* 40-50s  
|
|
|
+
+
Line 425: Line 411:
|
|
* 50s
* 50s
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 449: Line 434:
* Normal  
* Normal  
|-
|-
! colspan="18" |Genetic
! colspan="17" |Genetic
|-
|-
|Becker muscular dystrophy
|Becker muscular dystrophy
|<13yrs
|<13yrs
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 478: Line 462:
|Duchenne muscular dystrophy
|Duchenne muscular dystrophy
|<13 yrs
|<13 yrs
|
| +
| +
| -
| -
Line 505: Line 488:
|Limb-girdle muscular dystrophies
|Limb-girdle muscular dystrophies
|<15 yrs
|<15 yrs
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 535: Line 517:
|-
|-
|Myotonic dystrophy type 1
|Myotonic dystrophy type 1
|
|
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
Line 555: Line 536:
|
|
|
|
|
| colspan="2" |
|
|
|
|
|
|
|
|-
|-
! colspan="18" |Infectious
! colspan="17" |Infectious
|-
|-
|Lyme disease
|Lyme disease
|Variable
|Variable
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 596: Line 575:
|Infulenza
|Infulenza
|Variable
|Variable
|
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 625: Line 603:
|Polio
|Polio
|<5 yrs
|<5 yrs
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 656: Line 633:
|Syphilis
|Syphilis
|Variable
|Variable
|
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 690: Line 666:
|Pyomyositis
|Pyomyositis
|Variable
|Variable
|
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
Line 717: Line 692:
* -
* -
|-
|-
! colspan="18" |Neurologic
! colspan="17" |Neurologic
|-
|-
|ALS
|ALS
|
|
|
|
|
Line 739: Line 713:
|-
|-
|Stroke
|Stroke
|>65
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|
|
* Dysphagia
* Unilateral/Bilateral weakness
|
|
* H/o HTN, dyslipedemia DM
|
|
|
* Weakness of the involved arm
|
*
|
| colspan="2" |
|
|
|
|
|
|
|
|
|
|
|
|
Line 758: Line 735:
|-
|-
|GBS
|GBS
|
|
|
|
|
Line 777: Line 753:
|-
|-
|Multiple Sclerosis
|Multiple Sclerosis
|
|
|
|
|
Line 795: Line 770:
|
|
|-
|-
! colspan="18" |Neuro-muscular  
! colspan="17" |Neuro-muscular  
|-
|-
|Botulisim
|Botulisim
|
|
|
|
|
Line 817: Line 791:
|-
|-
|Lambert-Eaton myaes
|Lambert-Eaton myaes
|
|
|
|
|
Line 836: Line 809:
|-
|-
|Myasthenia gravis
|Myasthenia gravis
|
|
|
|
|
Line 854: Line 826:
|
|
|-
|-
! colspan="18" |Paraneoplastic
! colspan="17" |Paraneoplastic
|-
|-
|
|
|
|
|
Line 875: Line 846:
|
|
|-
|-
! colspan="18" |Metabolic
! colspan="17" |Metabolic
|-
|-
|Glycogen storage disease
|Glycogen storage disease
|
|
|
|
|
Line 897: Line 867:
|-
|-
|Lipid storage disease
|Lipid storage disease
|
|
|
|
|
Line 916: Line 885:
|-
|-
|Mitochondrial
|Mitochondrial
|
|
|
|
|

Revision as of 23:02, 3 April 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Differentiating Various Muscle Weakness

Disease Symptoms History Physical

Examination

Diagnosis
Age of onset Muscle weakness Fever Muscle pain Gait abnormality Neuropathy Myoglobinuria Other features Laboratory Findings Creatine Kinase Muscle Biopsy Electromyogram
Proximal DIstal
Medications
Corticosteroids
  • Variable
+ - - + - - -
  • + History of medications
  • Facial and sphincter muscles usually are spared
- - -
Statins
  • 60+
+ - - + - - -/+(rhabdomyolysis)
  • N/A
  • Positive medication history
  • Tenderness
  • Muscle aches
  • ↑↑ liver enzymes
  • ↑↑
  • Necrosis
  • Degeneration, and regeneration of fibers
  • Phagocytic infiltration
-
Alcohol
  • Variable
+ - - - + +/- -
  • Swelling
  • Tender
  • Erythema and induration
  • Alcohol intoxication
  • Change in mental status
  • Telangiectasia
  • Peripheral neuropathy
  •  nonspecific and are normal in many patients
  • Normal or ↑↑
  • Normal
  • Normal
Endocrine
Cushing's disease
  • 25 -45
+ - - - - - -
  • Decreased libido
  • Obesity/weight gain
  • Plethora
  • Round face
  • Menstrual changes
  • Hirsutism
  • Hypertension
  • Ecchymoses
  • Lethargy, depression
  • Dorsal fat pad
  • Abnormal glucose tolerance
  • N/A
  • Facial and sphincter muscles usually are spared
  • Overweight
  • Straie
  • Moon face
  • HTN
  • Hyperpigmentation
Normal
  • Atrophy of type 2 muscle fibers, especially type 2B
Normal
Adrenal insufficiency
  • 30-50 years
+ - - - - - -
  • Signs of glucocorticoid, mineralocorticoid, and, androgen deficiency.
  • Hypotension 
  • Hyperpigmentation 
  • Auricular-cartilage calcification 
  • Vitiligo
  • Electrolyte abnormalities
  • Hypoglycemia 
  • Normal
  • Normal
  • Normal
Hyperaldosteronism with myopathy 
  • 50
+ + - - - - +

Rhabdomyolysis

  • Palpitations
  • Hypertension
  • Episodes of heart beats
  • Hyperpigmentation
  • Hypokalemia
  • Normal
  • Normal
  • Normal
Hyperthyroidism
  • 40
+ - - - - - +
  • Signs of hyperthyroidism
  • Sweating
  • Tremor'
  • H/o of weight loss
  • Sweating
  • Tremor'
  • Swelling on neck examination
  • Decreased TSH
  • ↑↑
  • Non specific
  • Myotonic
Hypothyroidism
  • >55
+ - - + - - + Rhabdomyolysis
  •  Signs of hypothyroidism
  • H/o weight gain
  • Myoedema 
  • Muscle pseudohypertrophy
  • Increased TSH
  • ↑↑
  • Nonspecific 
  • Normal
Diabetic infraction
  • 45 
+ - + + - + -
  • Cramps
  • Sudden onset of pain
  • Anterior thigh muscles are most commonly involved
  • H/O long standing diabetes
  • Swelling
  • Tenderness
  • Elevation of the erythrocyte sedimentation rate
  • Leukocytosis
  • Normal
  • Necrosis
  • Edema
  • Normal
Inflammatory / Rheumatologic
Dermatomyositis[1]
  • 40s-50s
  • Can affect childreen
+ - + + - - -
  • Rash
  • Dyspnea
  • Weight loss
  • Cough
  • Heliotrope rash on face and hands
  • Telangectasia
  • Erythema
  • Mechanic's hands
  • Gottron's sign ( violaceous scaly eruption )
  • ↑↑
  • Perimysial mononuclear infiltrate
  • Muscle inflammation and damage
Polymyositis[2]
  • > 18 years
+ - + + - - - - -
  • ↑↑
  • Endomysial mononuclear infiltrate
  • Patchy necrosis
Inclusion body myositis[3]
  • 50s
+ +
  • ↑↑
Fibomyalgia
  • 40-50s

+

- - - - ++ -
  • Anxiety or depression features
  • Fatigue
  • Sleep disturbance
  • Numbness
  • Muscle spasms
  • History of depressive disorder
  • Tenderness in the soft tissue anatomical location
  • Normal
  • Normal
  • Normal
  • Normal
Polymyalgia Rheumatica[4]
  • 50s
+ - + + - - -
  • Weight loss
  • History of joints stiffness which is worse in the morning
  • Restricted shoulder motion
  • ↑ CRP
  • ↑ ESR
  • Normal
  • Normal
  • Normal
Genetic
Becker muscular dystrophy <13yrs + - - - + - -
  • Milder form of Duchenne
  • ↑↑
    • Muscle fibril degeneration, regeneration
    • Isolated fiber hypertrophy
    • Muscle replacement with fat and connective tissue
  • Weakness is caused by destruction of muscle.
Duchenne muscular dystrophy <13 yrs + - - - + - -
  • Calf psedohypertrophy
  • Cardiomyopathy
  • Kyphoscoliosis
  • Cognitive impairment
  • +Grower sign
  • ↑↑
Limb-girdle muscular dystrophies <15 yrs + - - + + - -
  • Calf hypertrophy
  • Scapular winging
  • Cardiomyopathy
  • Cardiac arrhythmias
  • Respiratory muscle weakness
  • Autosomal dominant
  • LMNA gene
  • CAV3 gene
  • ↑↑
  • -
Myotonic dystrophy type 1 + + - - + - -
  • Myotonia
  • Cataracts
  • Diabetes mellitus
  • Frontal balding
  • Cardiac arrhythmias
  • Cholecystitis
  • Pregnancy
  • Eyelid ptosis
Infectious
Lyme disease Variable + - + + +/- + -
  • + Tick bite
  • Hiking/Tip
  • Clinical diagnosis
  • +Serology
  • -
  • -
  • -
Infulenza Variable - - + + + - +
  • Fever
  • Malaise
  • Rhinorrhea
  • Muscle pain worse with movement
  • Muscle weakness, tenderness, and swelling.
  • ↑↑ Liver enzymes
  • +PCR
  • ↑↑
  • -
  • -
Polio <5 yrs + - - - + + -
  • Isolation from pharyngealsecretions, CSF
  • +Serology
  • -
  • -
  • Neurological pattern
Syphilis Variable - - - - + + -
  • Chancre
  • Lymphadenopathy
  • Condylomata lata
  • Neuro syphilis
  • Cardiovascular syphilis
  • History of risk factors (MSM, unprotected sex, multiple sex partners)
  • Darkfield examinations
  • VDRL
  • RPR
  • FTA-ABS
  • -
  • -
  • -
Pyomyositis Variable +/- +/- + + - - -
  • Fever
  • Malaise
  • Psoas abscess
  • Immunocopmprimised
    • Muscles are painful, swollen, tender, and indurated.
    • Depending on the site of involvement, it may mimic appendicitis (psoas muscle), septic arthritis of the hip (iliacus muscle), or epidural abscess (piriformis muscle).
  • Leukocytosis
  • Elevated ESR
  • -
  • -
  • -
Neurologic
ALS
Stroke >65 + + - - + + -
  • Dysphagia
  • Unilateral/Bilateral weakness
  • H/o HTN, dyslipedemia DM
  • Weakness of the involved arm
GBS
Multiple Sclerosis
Neuro-muscular
Botulisim
Lambert-Eaton myaes
Myasthenia gravis
Paraneoplastic
Metabolic
Glycogen storage disease
Lipid storage disease
Mitochondrial
  1. Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
  2. Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
  3. Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
  4. Myklebust G, Gran JT (1996). "A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis". Br J Rheumatol. 35 (11): 1161–8. PMID 8948307.